Arbutus Biopharma Corp (ABUS)

$4.28 +4.14%

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-08-04 ESTIMATED

Arbutus Biopharma Corp (ABUS) has a 48-report earnings history dating back to May 14, 2014. Its average absolute post-earnings move is ±4.04%, and 35.4% of those reactions were positive. Its largest post-earnings gain was +19.27% (Nov 02, 2017) and its largest decline was -13.74% (Mar 04, 2021). The next earnings report is predicted for 2026-08-04 (estimated).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

Avg Abs. Movement

±4.04%

Positive %

35.4%

Negative %

64.6%

Historical Earnings Statistics

Date	Timing	Open	High	Close	Volume	Movement %	SEC Filing
May 13, 2026	☀ PRE	$4.43	$4.50	$4.32	76,601	-0.23%	open_in_new
Mar 23, 2026	☀ PRE	$4.36	$4.60	$4.42	7,626,000	+4.25%	open_in_new
Nov 13, 2025	☀ PRE	$4.78	$4.83	$4.56	1,526,700	-5.79%	open_in_new
Aug 06, 2025	☀ PRE	$3.44	$3.55	$3.47	1,301,500	+1.76%	open_in_new
May 14, 2025	☀ PRE	$3.15	$3.23	$3.16	806,000	-0.94%	open_in_new
Mar 27, 2025	☀ PRE	$3.35	$3.39	$3.27	1,448,100	-2.39%	open_in_new
Nov 06, 2024	☀ PRE	$3.85	$3.96	$3.92	1,546,200	-1.01%	open_in_new
Aug 01, 2024	☀ PRE	$3.64	$3.84	$3.81	1,281,900	+1.06%	open_in_new
May 02, 2024	☀ PRE	$2.64	$2.73	$2.68	673,200	-0.37%	open_in_new
Feb 29, 2024	☀ PRE	$2.87	$2.87	$2.80	1,066,900	-2.78%	open_in_new
Nov 07, 2023	☀ PRE	$1.81	$1.86	$1.85	678,500	-1.6%	open_in_new
Aug 03, 2023	☀ PRE	$2.13	$2.13	$2.06	718,500	-0.96%	open_in_new
May 04, 2023	☀ PRE	$2.50	$2.57	$2.55	620,800	+1.59%	open_in_new
Mar 02, 2023	☀ PRE	$2.81	$2.81	$2.81	444,000	+0%	open_in_new
Nov 09, 2022	☀ PRE	$2.34	$2.56	$2.44	567,000	-0.81%	open_in_new
Aug 04, 2022	☀ PRE	$2.50	$2.56	$2.54	1,592,200	+3.25%	open_in_new
May 05, 2022	☀ PRE	$2.59	$2.59	$2.55	1,232,200	+2.41%	open_in_new
Mar 03, 2022	☀ PRE	$3.09	$3.22	$2.95	2,947,600	-4.53%	open_in_new
Nov 04, 2021	☀ PRE	$3.90	$4.16	$3.88	1,844,000	+0.78%	open_in_new
Aug 05, 2021	☀ PRE	$2.79	$3.12	$3.04	2,617,400	+10.14%	open_in_new
May 05, 2021	☀ PRE	$3.22	$3.22	$2.96	2,731,400	-11.11%	open_in_new
Mar 04, 2021	☀ PRE	$3.57	$3.60	$3.14	4,444,400	-13.74%	open_in_new
Nov 05, 2020	☀ PRE	$2.87	$3.05	$2.87	1,600,700	-6.21%	open_in_new
Aug 07, 2020	☀ PRE	$3.91	$4.04	$3.80	11,335,200	-13.04%	open_in_new
May 11, 2020	☀ PRE	$1.48	$1.50	$1.44	1,654,300	+6.67%	open_in_new
Mar 05, 2020	☀ PRE	$3.01	$3.09	$3.00	253,200	-0.99%	open_in_new
Nov 06, 2019	☀ PRE	$1.45	$1.49	$1.45	638,300	-2.68%	open_in_new
Aug 05, 2019	☽ POST	$1.67	$1.76	$1.60	207,900	+3.12%	open_in_new
May 06, 2019	☽ POST	$2.57	$2.79	$2.63	528,900	-6.08%	open_in_new
Mar 07, 2019	☽ POST	$4.02	$4.16	$4.02	103,900	-7.96%	open_in_new
Nov 07, 2018	☽ POST	$4.76	$4.99	$4.95	239,900	+9.09%	open_in_new
Aug 03, 2018	☽ POST	$11.85	$12.60	$9.65	1,504,200	-2.07%	open_in_new
May 03, 2018	☽ POST	$5.70	$6.08	$5.85	141,000	+0.85%	open_in_new
Mar 14, 2018	☽ POST	$5.90	$5.91	$5.65	196,900	-7.08%	open_in_new
Nov 02, 2017	☽ POST	$5.30	$5.80	$5.45	569,400	+19.27%	open_in_new
Aug 03, 2017	☽ POST	$3.55	$3.60	$3.40	16,200	+1.47%	open_in_new
May 04, 2017	☽ POST	$3.35	$3.40	$3.35	98,400	-1.49%	open_in_new
Mar 21, 2017	☀ PRE	$3.35	$3.40	$3.20	564,100	-4.48%	open_in_new
Nov 03, 2016	☽ POST	$3.05	$3.10	$3.05	67,000	-3.28%	open_in_new
Aug 05, 2016	☽ POST	$3.95	$4.04	$4.02	284,500	-1.99%	open_in_new
May 04, 2016	☽ POST	$4.88	$4.88	$4.64	139,800	-2.8%	open_in_new
Mar 09, 2016	☀ PRE	$3.97	$3.98	$3.88	214,300	-2.02%	open_in_new
Nov 05, 2015	☽ POST	$6.04	$6.12	$5.77	700,500	+2.77%	open_in_new
Aug 05, 2015	☽ POST	$10.20	$10.50	$10.33	299,500	-3.68%	open_in_new
May 06, 2015	☽ POST	$14.50	$14.55	$14.42	665,200	-3.81%	open_in_new
Mar 12, 2015	☽ POST	$18.60	$18.69	$17.85	580,200	-0.39%	open_in_new
Nov 06, 2014	☽ POST	$14.83	$16.69	$15.76	1,714,100	+6.28%	open_in_new
May 14, 2014	☽ POST	$12.50	$12.57	$12.02	281,900	-2.91%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±4.04%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260610	open_in_new SEC.gov
4	20260610	open_in_new SEC.gov
S-8	20260605	open_in_new SEC.gov
8-K	20260527	open_in_new SEC.gov
SCHEDULE 13G/A	20260515	open_in_new SEC.gov
10-Q	20260513	open_in_new SEC.gov
8-K	20260513	open_in_new SEC.gov
SCHEDULE 13D/A	20260428	open_in_new SEC.gov
SCHEDULE 13D/A	20260428	open_in_new SEC.gov
8-K	20260415	open_in_new SEC.gov

Frequently asked about ABUS earnings

When does Arbutus Biopharma Corp report earnings next? expand_more

Arbutus Biopharma Corp (ABUS)'s next earnings date is estimated for 2026-08-04. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does ABUS stock move after earnings? expand_more

Over 48 reports, ABUS has moved an average of ±4.04% the session after earnings, closing higher 35.4% of the time.

What was ABUS's biggest post-earnings move? expand_more

ABUS's largest post-earnings gain on record was +19.27% on Nov 02, 2017, and its largest decline was -13.74% on Mar 04, 2021.

Where can I find Arbutus Biopharma Corp's SEC filings? expand_more

All of Arbutus Biopharma Corp's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.